Loading this page
Bringing the next page into view.
Blueprint Intelligence / LP Archetypes / Family offices, endowments, or pensions: which should I approach first?
LP Archetypes
Start with the institutions whose mandate and process fit the fund you can present today. Category labels help with research, but they do not tell you who can commit.
A family office may offer a direct route to a decision-maker. An endowment may have a dedicated emerging-manager program. A pension may need a process and ticket size that your first fund cannot yet accommodate. Those are useful possibilities to investigate, not rules for ordering every raise. Compare actual mandates, access, decision calendars and diligence requirements against your evidence and runway. The strongest first conversation is one you have a credible reason to pursue.
Read each line as a tendency with wide variance inside it, because that is what it is.
Cambridge Associates, describing its own venture practice, states that a majority of the top-quartile performers in a given vintage year are emerging managers raising one of their first few funds. That is the reason a serious allocator in any of these three categories looks at first funds at all, and it says nothing about which of them will look at yours.
A sequencing plan is a runway decision before it is a relationship decision. You are choosing which processes you can afford to complete before your own money runs out.
Some institutional access is published rather than personal, and a first-time manager should know which doors have written criteria on them.
ILPA's Emerging Manager Showcase publishes its own: it is aimed at managers raising a first or second fund, meaning a first institutional fund or a small spinout, it excludes infrastructure, real assets, and real estate, it names a minimum target fund size of 100 million dollars, and applicants are reviewed and qualified by a committee of limited partners. Those are that programme's criteria rather than a market standard, and they are a useful illustration that some institutional routes state exactly who they are for.
Public and quasi-public programmes are the other written-criteria category, and Blueprint carries directories of both: forty-five state venture programmes and twenty-five development finance institutions, each with its own published routes and as-of date.
The three categories exist almost everywhere and their relative weight does not.
The questions overlap more than the processes do.
It does not tell you which specific institution to approach, and it deliberately names none. Every category here contains institutions that behave nothing like the description above, which is why the mandate-fit page exists and why qualification happens per institution rather than per label.
It also does not rank the capital. A family office commitment is not a lesser commitment than a pension one; they are different instruments with different consequences for concentration, governance, and re-up.
This page is educational and general. It is not legal, tax, securities, or investment advice.
Source check recorded: August 4, 2026.
The date records the source check, not a guarantee that the position is unchanged. Confirm current rules and requirements with the original source and your qualified advisers before relying on them for a decision.
Check your sequencing plan
Use a PDF or Word version of your target list or raise plan to review the proposed sequence against these investor categories. Confirm actual mandates and calendars directly with the institutions.
One PDF or DOCX, up to 15 MiB. Three successful free reads are shared across the library; no account is needed. This is an initial review, not an eligibility decision or a fund rating.
Perspectives by Colibrí Strategies: practical notes for GPs and the LPs who back them.
Opens Substack in a new tab, where you confirm the subscription.
Continue in this pillar
Also relevant
Choose the LP audience and add the materials they will see. Blueprint builds an evidence-based question and answer preparation pack for the conversation.